MDxHealth SA Net Income 2018-2025 | MDXH
MDxHealth SA net income from 2018 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| MDxHealth SA Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $-38 |
| 2023 | $-43 |
| 2022 | $-44 |
| 2021 | $-29 |
| 2020 | $-29 |
| 2019 | $-43 |
| 2018 | $-32 |
| 2017 | $-12 |
| 2016 | $-13 |
| MDxHealth SA Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-9 |
| 2024-12-31 | $-7 |
| 2024-09-30 | $-11 |
| 2024-06-30 | $-12 |
| 2024-03-31 | $-9 |
| 2023-12-31 | $-11 |
| 2023-09-30 | $-10 |
| 2023-06-30 | $-11 |
| 2023-03-31 | $-12 |
| 2022-12-31 | |
| 2022-09-30 | $-14 |
| 2022-06-30 | |
| 2022-03-31 | $-8 |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| 2020-06-30 | |
| 2019-12-31 | |
| 2019-06-30 | |
| 2018-12-31 | |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.097B | $0.090B |
| MDxHealth SA is a healthcare company which provides actionable molecular diagnostic information for diagnosis and treatment of cancer. The company's tests are based on proprietary gene methylation and other molecular technologies and assist physicians with the diagnosis of cancer. MDxHealth SA is headquartered in Herstal, Belgium. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.320B | 52.93 |
| Hims & Hers Health (HIMS) | United States | $11.979B | 124.46 |
| Tempus AI (TEM) | United States | $10.204B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.547B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.305B | 67.26 |
| Privia Health (PRVA) | United States | $2.816B | 192.50 |
| Enovis (ENOV) | United States | $1.849B | 10.31 |
| Clover Health Investments (CLOV) | United States | $1.669B | 0.00 |
| Schrodinger (SDGR) | United States | $1.550B | 0.00 |
| Phreesia (PHR) | United States | $1.447B | 0.00 |
| Omnicell (OMCL) | United States | $1.351B | 23.83 |
| Azenta (AZTA) | United States | $1.283B | 59.64 |
| 10x Genomics (TXG) | United States | $1.052B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.625B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.529B | 0.00 |
| Claritev (CTEV) | United States | $0.479B | 0.00 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Talkspace (TALK) | United States | $0.462B | 138.00 |
| Standard BioTools (LAB) | United States | $0.363B | 0.00 |
| TruBridge (TBRG) | United States | $0.356B | 789.67 |
| Outset Medical (OM) | United States | $0.327B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.283B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.193B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.136B | 0.00 |
| Pulmonx (LUNG) | United States | $0.126B | 0.00 |
| American Well (AMWL) | United States | $0.116B | 0.00 |
| CareCloud (CCLD) | United States | $0.087B | 3.31 |
| 111 (YI) | China | $0.067B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.055B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.051B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |